Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...
Cancer researchers found that patients on GLP-1s had significant risk reductions for 10 of 13 obesity-associated cancers.
New Rule Seeks to Expand Medicare and Medicaid Coverage of Weight Loss Drugs. The Biden Administration has proposed a new ...
Just how much Medicare price negotiations will negatively impact Novo Nordisk, though, depends on what the final negotiated ...
Leading health experts challenge traditional BMI measurements and introduce a comprehensive new approach to diagnosing obesity, potentially affecting millions.
New recommendations on how to define obesity would reduce the emphasis on body mass index and also take into account health ...
Obesity affects over 1 billion people globally, with 40 percent of U.S. adults classified as obese under the present ...
An international team of doctors proposed a new way to define obesity that's not based solely on BMI. Here's what they ...
An international commission made the case for focusing on body fat quantity and the illnesses people experience.
Over 75 medical organisations worldwide have endorsed the new definitions, reflecting a growing consensus for reform.
The risk of heart attack and stroke declines, but gastrointestinal problems and joint inflammation increase: New research has shed more light on the pros and cons of weight-loss jabs.